DBV Technologies S.A. - 8-K Filing
DBV Technologies reports Q3 2026 net loss of $64.5 million and submits VIASKIN® Peanut Patch BLA for children aged 4-7 to U.S. FDA. (Items: 2.02 Results of Operations and Financial Condition On October 28, 2026, DBV Technologies S, 9.01 Financial Statements and Exhibits)
Tickers: $DBVT